Dl-Tryptophan

Dl-Tryptophan

SCHEMBL23924440

CSCCC(N)C(=O)O.CSCCC(N)C(=O)O.NC(Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.76
KDM4E B2RXH2 3/20 0.76
MAPT P10636 3/20 0.76
MEN1 O00255 3/20 0.76
LMNA P02545 2/20 0.76
TSHR P16473 2/20 0.76
BLM P54132 2/20 0.76
PMP22 Q01453 2/20 0.76
MPO P05164 1/20 0.76
HIF1A Q16665 1/20 0.76
CTSC P53634 3/20 0.66
APAF1 O14727 1/20 0.57
POLB P06746 1/20 0.57
RECQL P46063 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.55
HTR2A P28223 3/20 0.54
HTR1A P08908 2/20 0.54
HTR2C P28335 2/20 0.54
SLC6A4 P31645 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tryptophan SCHEMBL2229691 1.00 KMT2A (0.76) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL11461241 1.00 KMT2A (0.76) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL2229687 1.00 KMT2A (0.76) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL8937030 0.96 KMT2A (0.70) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL3827133 0.96 KMT2A (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL23924534 0.96 KMT2A (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL27596671 0.94 KMT2A (0.67) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL7978131 0.93 KMT2A (0.65) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL7978129 0.93 KMT2A (0.65) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL3863016 0.93 KMT2A (0.65) KMT2AKDM4EMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210324027-A1 MODIFIED INTERLEUKIN-7 PROTEINS AND USES THEREOF GENEXINE, INC. (KR) 2021-10-21 US claimed
US-20210324027-A1 MODIFIED INTERLEUKIN-7 PROTEINS AND USES THEREOF GENEXINE, INC. (KR) 2021-10-21 US disclosed